MetLife Investment Advisors »

Arcturus Therapeutics Hldg I shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $389k 12k 31.53
2023-09-30 $315k 12k 25.55
2023-06-30 $354k 12k 28.68
2023-03-31 $296k 12k 23.97
2022-12-31 $209k 12k 16.96
2022-09-30 $183k 12k 14.82
2022-06-30 $194k 12k 15.74
2022-03-31 $332k 12k 26.96
2021-12-31 $274k 7.4k 37.01
2021-09-30 $354k 7.4k 47.78
2021-06-30 $302k 8.9k 33.78
2021-03-31 $369k 8.9k 41.28
2020-12-31 $388k 8.9k 43.41
2020-09-30 $304k 7.1k 42.90
2020-06-30 $282k 6.0k 46.66